|
|
||||||||
American Journal of Clinical Nutrition, Vol 59, 423-427, Copyright © 1994 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
RT Stanko, HR Reynolds, R Hoyson, JE Janosky and R Wolf
Department of Medicine, Montefiore University Hospital, Pittsburgh, PA 15213-2582.
The effects of the three-carbon compound pyruvate on plasma lipid concentrations and body composition were evaluated in hyperlipidemic patients consuming a low-cholesterol (165-180 mg), low-fat (22-24% of energy; 18-20% of energy as saturated fatty acid) diet (0.091-0.099 MJ.kg body wt-1 x d-1). After consuming the above diet for 4 wk, during which time plasma lipid concentrations decreased, 34 subjects were randomly assigned to receive either 22-44 g pyruvate (n = 17) or 18-35 g polyglucose (placebo, Polycose, n = 17), iso-energetically substituted for a portion of carbohydrate energy for 6 wk. Despite greater weight and fat losses with pyruvate (P < 0.05), plasma concentrations of cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride were not different between the two groups of subjects. We conclude that subsequent to diet-induced reduction in plasma lipid concentrations, pyruvate supplementation of a low-cholesterol, low-fat diet providing 6.7-7.6 MJ/d for 6 wk has no effect on plasma lipid concentrations but enhances body weight and fat losses.
This article has been cited by other articles:
![]() |
L. Wilson, Q. Yang, J. D. Szustakowski, P. S. Gullicksen, and R. Halse Pyruvate induces mitochondrial biogenesis by a PGC-1 {alpha}-independent mechanism Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1599 - C1605. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H Pittler and E. Ernst Dietary supplements for body-weight reduction: a systematic review Am. J. Clinical Nutrition, April 1, 2004; 79(4): 529 - 536. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |